Academic background&position

data loading...

1. [SCIE] AXL receptor tyrosine kinase inhibition improves the anti-tumor effects of CD8+ T cells by inducing CD103+ dendritic cell-mediated T cell priming [BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS] - 2023-11-05
2. [SCIE] Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancer [Biomarker Research] - 2023-09-13
3. [SCIE] Generation of genetically engineered mice for lung cancer with mutant EGFR [BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS] - 2022-12-03
4. [SCIE] A Phase I/IIa Randomized Trial Evaluating the Safety and Efficacy of SNK01 Plus Pembrolizumab in Patients with Stage IV Non-Small Cell Lung Cancer [CANCER RESEARCH AND TREATMENT] - 2022-10-01
5. [SCIE] Contribution of p53 in sensitivity to EGFR tyrosine kinase inhibitors in non-small cell lung cancer [SCIENTIFIC REPORTS] - 2021-10-04